| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 25 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| 2 | TACROLIMUS OINTMENT 0.1% | 24 |
| 3 | PREDNISONE | 20 |
| 4 | PREDNISOLONE | 17 |
| 5 | PREDNISOLONE ORAL | 17 |
| 6 | PREDNISOLONE ORAL SOLUTION | 17 |
| 7 | CYCLOPHOSPHAMIDE | 8 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILTEFOSINE | 3 | 0.0077 |
| 1 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 2 | FLUCYTOSINE | 2 | 0.0014 |
| 3 | CARMUSTINE | 5 | 0.0011 |
| 4 | DACARBAZINE | 6 | 0.0008 |
| 5 | ATOVAQUONE | 6 | 0.0007 |
| 6 | BLEOMYCIN SULFATE | 6 | 0.0006 |
| 7 | BRENTUXIMAB VEDOTIN | 6 | 0.0006 |
| 8 | AMPHOTERICIN B | 7 | 0.0005 |
| 9 | ALBENDAZOLE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 1 | CD30-directed Immunoconjugate [EPC] | 6 | 0.0006 |
| 2 | Antimalarial [EPC] | 6 | 0.0006 |
| 3 | Antiprotozoal [EPC] | 6 | 0.0006 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 7 | 0.0005 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |